Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Update on Rotavirus Vaccine

In March 2010, FDA became aware of the presence PCV1 in Rotarix and DNA from PCV1 and PCV2 in RotaTeq. These viruses are not known to cause any infection or illness in people. Based on a careful review of a variety of scientific information, FDA has determined it is appropriate for clinicians and public health professionals in the United States to use these vaccines. All available evidence supports the safety and effectiveness of Rotarix and RotaTeq, which have been extensively studied, both before and after approval.

This web page provides additional background information and Questions and Answers for patients and providers.

About Rotavirus, PCV, and the Rotavirus Vaccines:

Additional Background Information

Resources for You

Page Last Updated: 12/28/2010
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.